Hepatitis
Sofokast Plus Tablet
SKU: SOFOKAST-PLUS-TABLET
Active Pharmaceutical Ingredient
DACLATASVIR,SOFOSBUVIR
Product Information
Sofokast Plus tablet contains the active ingredient Daclatasvir. It is an Anti-Viral drug that belongs to a group of medicines called hepatitis C virus (HCV) NS5A inhibitors. It is used along with another medication to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). It works by stopping the virus that causes hepatitis C from spreading inside the body. Do not take Sofokast Plus tablet if you are allergic to Daclatasvir or any of the other ingredients. This medicine must always be used in combination with other medicines against hepatitis C infection. Inform your doctor if you have an irregular heartbeat or liver injury before initiating the treatment. Report to your doctor if you have shortness of breath, lightheadedness, palpitations, and fainting while taking this medicine. Sofokast Plus tablet is not recommended for patients below 18 years of age. Do not take this medicine if you are pregnant or breastfeeding. Use effective contraception during the treatment. The common side effects of this treatment are headache, tiredness, anemia, and nausea. Chronic hepatitis C virus
• Chronic hepatitis C virus
This medicine works by stopping the hepatitis C virus from multiplying and infecting new cells. This lowers the amount of hepatitis C virus in your body and removes the virus from your blood over a period of time.
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
• Nausea
• Headache
• Tiredness
• Dizziness
• Headache
• Tiredness
• Dizziness
It is an orally available prescription drug. Your doctor will decide the dose and duration of Sofokast Plus tablet based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water.
• Breast Feeding: Breastfeeding is not recommended in patients taking Sofokast Plus tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
• Alcohol: It is unknown whether it is safe to drink alcohol while taking Daclatasvir. Consult your doctor for more information
• Liver: Sofokast Plus tablet is safe when administered in patients with liver diseases. Dose adjustments are not necessary. However, inform your physician if you have any liver diseases before initiating the therapy.
• Lungs: It is unknown whether Sofokast Plus tablet is safe to be administered in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
• Driving: It is unsafe to drive after Sofokast Plus tablet tablets because it may cause dizziness and drowsiness.
• Pregnancy: Do not take Sofokast Plus tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during and for 5 weeks after your last dose.
• Alcohol: It is unknown whether it is safe to drink alcohol while taking Daclatasvir. Consult your doctor for more information
• Liver: Sofokast Plus tablet is safe when administered in patients with liver diseases. Dose adjustments are not necessary. However, inform your physician if you have any liver diseases before initiating the therapy.
• Lungs: It is unknown whether Sofokast Plus tablet is safe to be administered in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
• Driving: It is unsafe to drive after Sofokast Plus tablet tablets because it may cause dizziness and drowsiness.
• Pregnancy: Do not take Sofokast Plus tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during and for 5 weeks after your last dose.
DISCOVER MORE
Related Products
APRAZER HEALTHCARE PVT LTD
Velakast Tablet
APRAZER HEALTHCARE PVT LTD
Entekor 0.5mg Tablet
APRAZER HEALTHCARE PVT LTD
Entekor 1mg Tablet
JASGUR LIFE SCIENCES LLP
Entewell 0.5mg Tablet
DR REDDY'S LABORATORIES LTD
Entaliv 0.5mg Tablet
ZYDUS CADILA
Entehep 0.5mg Tablet
Mylan Pharmaceuticals Pvt Ltd
Gepatit 0.5mg Tablet
WATERLEY PHARMACETICALS PVT LTD
